Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.2656 (2.11%) ($6.1208 - $6.4000) on Thu. Mar. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.39% (three month average) | RSI | 54 | Latest Price | $6.2656(2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -1.2% a day on average for past five trading days. | Weekly Trend | EYES advances 0.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UUP(9%) FIVG(6%) ICLN(6%) UNG(6%) | Factors Impacting EYES price | EYES will decline at least -2.195% in a week (0% probabilities). BND(-8%) VCIT(-6%) LQD(-6%) XLP(-5%) TIP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.195% (StdDev 4.39%) | Hourly BBV | 0 () | Intraday Trend | 1.7% | | | |
|
Resistance Level | $6.46 | 5 Day Moving Average | $6.44(-2.71%) | 10 Day Moving Average | $6.56(-4.49%) | 20 Day Moving Average | $6.46(-3.01%) | To recent high | -21.7% | To recent low | 14.3% | Market Cap | $2.001b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |